CaixaResearch

  • ALS: researching a disease still without a cure that affects more than 4,000 patients
    • Imágenes
    • Videos
    • Audios

    ALS: researching a disease still without a cure that affects more than 4,000 patients

    Amyotrophic lateral sclerosis (ALS) is the third most prevalent neurodegenerative disease in Spain. The "la Caixa" Foundation, in collaboration with the Fundación Luzón, is promoting research aimed at improving the diagnosis and treatment of this ...

    Read more
  • Overcoming superbugs, one of the great challenges of this century
    • Imágenes

    Overcoming superbugs, one of the great challenges of this century

    Every year, 1.2 million people around the world die from infections caused by antibiotic-resistant bacteria. According to the WHO, the ability of bacteria to adapt and resist drugs designed to combat them is already one of the biggest threats to ...

    Read more
  • Treating cancer when neither chemotherapy nor transplant works
    • Imágenes
    • Videos

    Treating cancer when neither chemotherapy nor transplant works

    Without the most common side effects, with improvement from the first days and complete remission after 18 months in almost 70% of cases. A clinical trial of CAR-T therapies coordinated by the Hospital Clínic Barcelona - IDIBAPS, with the support of ...

    Read more
  • The future of biomedical and health research in Spain and Portugal
    • Imágenes
    • Videos
    • Audios

    The future of biomedical and health research in Spain and Portugal

    It’s not every day that a group of scientists of the highest calibre from different disciplines meet up to discuss, share knowledge and jointly seek solutions to the current and future challenges facing their profession. This is precisely what ...

    Read more
  • ”la Caixa” Foundation supports three innovative biomedical projects to help them transfer from the lab to the market and society
    • Imágenes
    • Notas de prensa

    ”la Caixa” Foundation supports three innovative biomedical projects to help them transfer from the lab to the market and society

    The CaixaResearch Consolidate 2022 call for proposals resulted in the selection of three promising innovative biomedical projects. Each will receive funding of 300,000 euros to help their innovations reach the market and society as a whole.

    Read more